She plans to collaborate with researchers from the University’s College of Agriculture, Biotechnology & Natural Resources and ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

Institutional investors and hedge funds own 1.70% of the company’s stock. Origin Agritech Limited, together with its subsidiaries, operates as an agricultural biotechnology in the People’s Republic of ...

Agricultural scientist emphasizes climate-resilient crops for global food security through genomics-assisted breeding and rapid delivery systems.

DALLAS (AP) — DALLAS (AP) — Arcadia Biosciences Inc. (RKDA) on Tuesday reported a loss of $1.6 million in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of $1.18.

Austin Moeller, an analyst from Canaccord Genuity, maintained the Buy rating on Cibus (CBUS – Research Report). The associated price ...

Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago. These figures ...

The Vignan University is advancing with the noble objectives of creating top-notch job opportunities for the youth, ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

If the United States does not lead in emerging biotechnologies, our adversaries will, writes GOP Sen. Todd Young of Indiana.

A group of investors in Locus Solutions, a biotechnology company headquartered in Solon ... is an agtech business that has ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...